Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: A longitudinal open label trial

European Journal of Paediatric Neurology

Volumn 17, Issue 4, 2013, Pages 407-414

  Pasini, A ^a   Sinibaldi, L ^b   Paloscia, C ^a,e   Douzgou, S ^c   Pitzianti, M B ^a   Romeo, E ^a   Curatolo, P ^a   Pizzuti, A ^d  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e Association for Therapy and Research in Developmental Age and Adults (Clinical Center ASTREA)   (Italy)

Author keywords

ADHD; Dopamine transporter; Executive functions; Methylphenidate; Working memory

Indexed keywords

DOPAMINE TRANSPORTER; METHYLPHENIDATE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; GENE EXPRESSION; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MORNING DOSAGE; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; WORKING MEMORY;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COGNITION DISORDERS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENOTYPE; HUMANS; INHIBITION (PSYCHOLOGY); LONGITUDINAL STUDIES; MALE; MEMORY, SHORT-TERM; METHYLPHENIDATE; MINISATELLITE REPEATS; NEUROPSYCHOLOGICAL TESTS; PHARMACOGENETICS; PROBLEM SOLVING; PSYCHIATRIC STATUS RATING SCALES; TIME FACTORS;

EID: 84878839226     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2013.02.002     Document Type: Article

References (52)

1. G. Polanczyk, M.S. de Lima, B.L. Horta, J. Biederman, and L.A. Rohde The worldwide prevalence of ADHD: a systematic review and metaregression analysis Am J Psychiatry 164 2007 942 948
2. L.L. Greenhill, J.M. Halperin, and H. Abikoff Stimulant medications J Am Acad Child Adolesc Psychiatry 38 1999 503 512
3. D.J. Safer, and M. Malever Stimulant treatment in Maryland public schools Pediatrics 106 2000 533 539
4. J. Swanson, R.D. Baler, and N.D. Volkow Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress Neuropsychopharmacology 36 2011 207 226
5. T. Berman, V.I. Douglas, and R.G. Barr Effects of methylphenidate on complex cognitive processing in attention-deficit hyperactivity disorder J Abnorm Psychol 108 1999 90 105
6. A. Scheres, J. Oosterlaan, J. Swanson, S. Morein-Zamir, N. Meiran, and H. Schut The effect of methylphenidate on three forms of response inhibition in boys with AD/HD J Abnorm Child Psychol 31 2003 105 120
7. Kl Shue, and V.I. Douglas Attention deficit hyperactivity disorder and the frontal lobe syndrome Brain Cogn 20 1992 104 124
8. K. Rubia, R. Halari, A. Cubillo, A.M. Mohammad, M. Brammer, and E. Taylor Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task Neuropharmacology 57 2009 640 652
9. E.J. Sonuga-Barke, D. Coghill, M. DeBacker, and J. Swanson Measuring methylphenidate response in attention-deficit/hyperactvity disorder: how are laboratory classroom-based measures related to parent ratings? J Child Adolesc Psychopharmacol 19 2009 691 698
10. G. Bush, T.J. Spencer, J. Holmes, L.M. Shin, E.M. Valera, and L.J. Seidman Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task Arch Gen Psychiatry 61 2008 102 114
11. D.R. Coghill, S.M. Rhodes, and K. Matthews The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/ hyperactivity disorder Biol Psychiatry 62 2007 954 962
12. EMEA Questions and answers on the review of medicines containing methylphenidate 2008 Doc. Ref. EMEA/658285/2008
13. J.S. Kooij, A.M. Boonstra, S.H. Vermeulen, A.G. Heister, H. Burger, J.K. Buitelaar, and B. Franke Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1) Am J Med Genet B Neuropsychiatr Genet 147B 2008 201 208
14. T. Roman, L.A. Rohde, and M.H. Hutz Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder Am J Pharmacogenomic 4 2004 83 92
15. C.Y. Shang, S.S. Gau, C.M. Liu, and H.G. Hwu Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan Prog Neuropsychopharmacol Biol Psychiatry 2010 10.1016/j.pnpbp
16. M.S. Mazei-Robison, R.S. Couch, R.C. Shelton, M.A. Stein, and R.D. Blakely Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder Neuropharmacology 49 6 Nov 2004 724 736
17. N.D. Volkow, G.J. Wang, F. Telang, J.S. Fowler, J. Logan, A.R. Childress, M. Jayne, Y. Ma, and C. Wong Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues Neuroimage 39 3 2008 Feb 1 1266 1273
18. S.V. Faraone, and E. Mick Molecular genetics of attention deficit hyperactivity disorder Psychiatr Clin North Am 33 2010 159 180
19. B. Franke, A.A. Vasquez, S. Johansson, M. Hoogman, J. Romanos, and A. Boreatti-Hümmer Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD Neuropsychopharmacology 35 2010 656 664
20. P.A. Sáiz, M.P. García-Portilla, C. Arango, B. Morales, B. Arias, and P. Corcoran Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: data from an association study Prog Neuropsychopharmacol Biol Psychiatry 34 2010 26 31
21. C.S. van der Zwaluw, R.C. Engels, J. Buitelaar, R.J. Verkes, B. Franke, and R.H. Scholte Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review Pharmacogenomics 10 2009 853 866
22. B. Yang, R.C. Chan, J. Jing, T. Li, P. Sham, and R.Y. Chen A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder Am J Med Genet B Neuropsychiatr Genet 144B 4 2007 541 550
23. T.A. Greenwood, and J.R. Kelsoe Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene Genomics 82 5 2003 511 520
24. J. Mill, P. Asherson, C. Browes, U. D'Souza, and I. Craig Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR Am J Med Genet 114 2002 975 979
25. A. Heinz, D. Goldman, D.W. Jones, R. Palmour, D. Hommer, J.G. Gorey, K.S. Lee, M. Linnoila, and D.R. Weinberger Genotype influences in vivo dopamine transporter availability in human striatum Neuropsychopharmacology 22 2 2000 133 139
26. K.A. Cheon, Y.H. Ryu, J.W. Kim, and D.Y. Cho The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate Eur Neuropsychopharmacol 15 2005 95 101
27. J. Krause, C. la Fougere, K.H. Krause, M. Ackenheil, and S.H. Dresel Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD Eur Arch Psychiatry Clin Neurosci 255 2005 428 431
28. E. van de Giessen, M.M. de Win, M.W. Tanck, W. van den Brink, F. Baas, and J. Booij Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3 J Nucl Med 50 1 2009 45 52
29. J. Krause SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder Expert Rev Neurother 8 2008 611 625
30. M.A. Stein, I.D. Waldman, C.S. Sarampote, K.E. Seymour, A.S. Robb, and C. Conlon Dopamine transporter genotype and methylphenidate dose response in children with ADHD Neuropsychopharmacology 30 2005 1374 1382
31. D. Purper-Ouakil, M. Wohl, S. Orejarena, S. Cortese, C. Boni, and M. Asch Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3) Am J Med Genet B Neuropsychiatr Genet 147B 2008 1425 1430
32. J. Kaufman, B. Birmaher, D. Brent, U. Rao, and N. Ryan Kiddie-sads-present and lifetime version 1996 The Department of Psychiatry, University of Pittsburgh School of Medicine
33. Società Italiana di Neuropsichiatria Infantile (SINPIA) A. Zuddas, G. e Masi, Linee-guida per la diagnosi e la terapia farmacologica del Disturbo da Deficit Attentivo con Iperattività (ADHD) in età evolutiva 2002
34. C.K. Conners, G. Sitarenios, J.D. Parker, and J.N. Epstein Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity J Abnorm Child Psychol 26 1998 279 291
35. D. Schaffer, M.S. Gould, J. Brasic, P. Ambrosini, P. Fisher, and H. Bird A children's global assessment scale (CGAS) Arch Gen Psychiatry 40 1983 1228 1231
36. R. Krikorian, J. Bartok, and N. Gay Tower of London procedure: a standard method and developmental data J Clin Exp Neuropsychol 16 6 1994 840 850
37. T. Shallice Specific impairments of planning Philos Trans Royal Soc London B 298 1982 199 209
38. C.K. Conners Conners' continuous performance test 1995 Multi-Health Systems Toronto
39. T. Shallice Specific impairments of planning Philos Trans R Soc Lond B Biol Sci 1982
40. G. Szekeres, S. Kéri, A. Juhász, A. Rimanóczy, I. Szendi, and C. Czimmer Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia Am J Med Genet B Neuropsychiatr Genet 124B 2004 1 5
41. S. Fuke, S. Suo, N. Takahashi, H. Koike, N. Sasagawa, and S. Ishiura The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression Pharmacogenomic J 1 2001 152 156
42. J.S. Vles, F.J. Feron, J.G. Hendriksen, J. Jolles, M.J. van Kroonenburgh, and W.E. Weber Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD) Neuropaediatrics 34 2003 77 80
43. A. Kirley, N. Lowe, Z. Hawi, C. Mullins, G. Daly, I. Waldman, M. McCarron, D. O'Donnell, M. Fitzgerald, and M. Gill Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD Am J Med Genet B Neuropsychiatr Genet 121B 2003 50 54
44. A.M. Kang, M.A. Palmatier, and K.K. Kidd Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3) Biol Psychiatry 46 1999 151 160
45. R.J. Mitchell, S. Howlett, L. Earl, N.G. White, J. McComb, and M.S. Schanfield Distribution of the 3' VNTR polymorphism in the human dopamine transporter gene in world populations Hum Biol 72 2000 295 304
46. A. Santovito, P. Cervella, A. Selvaggi, G.P. Caviglia, C. Burgarello, and G. Sella DAT1 VNTR polymorphisms in a European and an African population: identification of a new allele Hum Biol 80 2008 191 198
47. M.A. Bellgrove, Z. Hawi, A. Kirley, M. Gill, and I.H. Robertson Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype Neuropsychologia 43 2005 1847 1857
48. R.M. Alderson, M.D. Rapport, and M.J. Kofler Attention-deficit/ hyperactivity disorder and behavioral inhibition: a meta-analytic review of the stop-signal paradigm J Abnorm Child Psychol 35 2007 745 758
49. P. Bitsakou, L. Psychogiou, M. Thompson, and E.J. Sonuga-Barke Inhibitory deficits in attention deficit/hyperactivity disorder are independent of basic processing efficiency and IQ J Neural Transm 115 2008 261 268
50. H.M. Huizenga, B.M. van Bers, J. Plat, W.P. van den Wildenberg, and M.W. van der Molen Task complexity enhances response inhibition deficits in childhood and adolescent attention deficit/hyperactivity disorder: a meta-regression analysis Biol Psychiatry 65 2009 39 45
51. F.J. Feron, J.G. Hendriksen, M.J. van Kroonenburgh, C. Blom-Coenjaerts, A.G. Kessels, and J. Jolles Dopamine transporter in attention-deficit hyperactivity disorder normalizes after cessation of methylphenidate Paediatr Neurol 33 2005 179 183
52. P. Curatolo, C. Paloscia, E. D'Agati, R. Moavero, and A. Pasini The neurobiology of attention deficit/hyperactivity disorder Eur J Paediatr Neurol 13 4 2009 299 304